Skip to search formSkip to main contentSkip to account menu

CKD 712

Known as: CKD-712, CKD712 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background and ObjectivesCKD-712, a candidate treatment for septic shock, acts by increasing cardiac output. This study… 
2015
2015
CKD-712, a newly synthesized tetrahydroisoquinoline (THI) and an enantiomer (S form) of YS 49 (a derivative of higenamine) has… 
2013
2013
Given the importance of VEGF and haem oxygenase (HO)‐1 in wound healing, the present study tested the hypothesis that CKD712, a… 
2011
2011
CKD-712 is a 1-naphthyl analog of higenamine that has been reported to have potent antiinflammatory and thus anti-sepsis effects… 
2011
2011
Since CKD-712 has been developed as an anti-inflammatory agent, we examined the effect of CKD-712 during TLR4 signaling. Using… 
2009
2009
We examined our hypothesis that (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) inhibits apoptosis… 
2009
2009
We examined our hypothesis that (S)-1-( -naphthylmethyl)-6,7dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) inhibits apoptosis… 
2007
2007
2389 Inflammation is commonly associated with carcinogenesis. CKD712, an S enantiomer of YS 49, is under phase I clinical trial…